10:45 AM EDT, 09/12/2024 (MT Newswires) -- Scilex ( SCLX ) said Thursday it has received the drug distributor accreditation from the National Association of Boards of Pharmacy.
The company acquires and develops non-opioid products for the treatment of acute and chronic pain.
Scilex ( SCLX ) shares were down more than 4% in recent trading.
Price: 1.04, Change: -0.05, Percent Change: -4.59